
LEQEMBI IQLIK, a weekly at-home injection for early Alzheimer's, now available in the U.S.
Eisai and Biogen have launched LEQEMBI IQLIK, the first weekly subcutaneous injection for early Alzheimer's disease, now available in the U.S. This treatment offers a convenient alternative to intravenous infusions, allowing patients to initiate and ...
